SCHEMBL24740667

SCHEMBL24740667

CCC1CC(N2CCCCC2)CC(CC)N1C

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.31
LTA4H P09960 1/20 0.31
HRH3 Q9Y5N1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24265304 0.76
SCHEMBL24718638 0.76 LTA4H (0.33) KMT2ALTA4H
SCHEMBL24717530 0.76 LTA4H (0.33) KMT2ALTA4H
SCHEMBL10191534 0.73 LTA4H (0.34) LTA4H
SCHEMBL8374122 0.71 LMNA (0.46) HRH3
SCHEMBL24740666 0.71 HTR6 (0.31) LTA4H
SCHEMBL18099726 0.69 FYN (0.33) LTA4H
SCHEMBL17947428 0.69 FYN (0.33) LTA4H
SCHEMBL12716816 0.67 FYN (0.35) LTA4HHRH3
SCHEMBL22055072 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022261120-A1 nSMASE2 INHIBITOR PRODRUGS WITH ENHANCED ORAL AND BRAIN EXPOSURES THE JOHNS HOPKINS UNIVERSITY (US) 2022-12-15 WO disclosed